Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DHX15 mRNA | decreases expression | 19150397
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of DHX15 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of DHX15 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of DHX15 mRNA | decreases expression | 17108234
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of DHX15 mRNA | increases expression | 16584549
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of DHX15 mRNA | increases expression | 16807920
|
D008727 |
Methotrexate |
DHX15 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D011374 |
Progesterone |
Progesterone results in decreased expression of DHX15 mRNA | decreases expression | 18037150
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of DHX15 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DHX15 mRNA | increases expression | 19465110
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
9.74 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.74 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.32 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.51 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.51 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
9.45 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.45 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.77 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.80 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.14 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.29 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.71 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.56 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.41 | 15136595 18357371 18608205 19217205 16557594 16595493 16110121 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.41 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.41 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.41 | 18815881 20065188 17049068 19289846 19189210 19410462 20390343 21152245 19487384 16273361 17893378 20859285 19288272 21138602 19221464 19200415 19189212 19059307 19011961 17242785 17261762 16873071 16202921 17440819 15668708 19066611 18855134 16818667 18425577 19244106 19115204 18997820 18351453 18821012 19103187 18984771 19084267 18629630 19142967 15565566 20005174 20544844 20135344 19155303 11161223 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.41 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
5.04 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.83 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.83 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.81 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
3.20 | 17045692 17971768 16332177 18930000 17088986 16799960 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.20 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.11 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.55 | 17066447 16280240 18986760 16757204 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.84 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.88 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.05 | 15861022 17333356 17110522 17681005 11677210 16919318 16105132 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 15340226 12621046 8697196 16354765 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.26 | 15001691 16340194 18772588 17169374 17725105 17018589 16510598 17016597 17172411 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 16331619 18802399 15148649 20501625 16524972 17594712 18383874 18288408 17695437 15289873 16282729 14970324 17401013 18509181 18448328 17016601 16391804 17094418 17454858 16303861 18949393 17255274 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.81 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 15322242 10048152 20055451 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.47 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.13 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.67 | 19031437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.41 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.69 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.80 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.59 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
17.03 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
17.03 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
17.03 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.19 | 20544844 17893378 19155303 16202921 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.70 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.70 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.68 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.68 | 16481741 15173087 16785472 16337965 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.51 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.51 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.37 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.87 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.52 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.95 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.45 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.54 | 15162350 15102660 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 16959395 15340226 16354765 18606429 8697196 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.12 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.71 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.72 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.64 | 17937319 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.97 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.97 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.97 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
8.19 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.19 | 18625569 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.36 | 9562676 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.32 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.82 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.34 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.34 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.88 | 16603448 17045692 15113037 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.88 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.88 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.40 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
3.52 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.52 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.52 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.13 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.12 | 17352296 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.10 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.57 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.57 | 19196723 19196722 14580682 16827153 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.92 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.52 | 15990972 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.81 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.62 | 17488658 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.63 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.58 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.71 | 16928823 18600527 18239605 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.38 | 19196722 19189210 19200415 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.59 | 16436463 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.58 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.73 | 16500647 16929163 15113037 19003803 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.95 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11118676 11222880 11896295 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.24 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.24 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.65 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.50 | 17410198 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.23 | 16160472 15538739 18722050 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
5.02 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.92 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.14 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.85 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.85 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
12.02 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
12.02 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 18567086 16424979 19015929 18396642 17522103 16951190 17498489 19084572 15786421 17172411 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.32 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.88 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.22 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.43 | 8653321 16712894 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.11 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.58 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.78 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |